P. Tsapogas, C. J. Mooney, G. Brown, and A. Rolink, The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis, Int J Mol Sci, vol.18, issue.6, p.1115, 2017.

J. M. Bertho, C. Demarquay, and J. Frick, Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia, Int J Radiat Biol, vol.77, issue.6, pp.703-712, 2001.

M. Prat, J. Frick, J. Laporte, D. Thierry, N. Gorin et al., Kinetics of plasma FLT3 ligand concentration in hematopoietic stem cell transplanted patients, Leuk Lymphoma, vol.47, issue.1, pp.77-80, 2006.

J. H. Haidar, A. Bazarbachi, R. Mahfouz, H. A. Haidar, H. Jaafar et al., Serum Flt3 ligand variation as a predictive indicator of hematopoietic stem cell mobilization, J Hematother Stem Cell Res, vol.11, issue.3, pp.533-538, 2002.

G. Meierhoff, U. Dehmel, and H. J. Gruss, Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines, Leukemia, vol.9, issue.8, pp.1368-1372, 1995.

K. Brasel, S. Escobar, R. Anderberg, P. De-vries, H. J. Gruss et al., Expression of the flt3 receptor and its ligand on hematopoietic cells, Leukemia, vol.9, issue.7, pp.1212-1218, 1995.

H. G. Drexler, Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells, Leukemia, vol.10, issue.4, pp.588-599, 1996.

R. Zheng, M. Levis, and O. Piloto, FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells, Blood, vol.103, issue.1, pp.267-274, 2004.

T. Sato, X. Yang, and S. Knapper, FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo, Blood, vol.117, issue.12, pp.3286-3293, 2011.

P. Chevallier, T. Eugene, and N. Robillard, 90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study, Lancet Haematol, vol.2, issue.3, pp.108-117, 2015.

J. E. Boissel, N. Chevret, and S. , Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia, Blood, vol.121, issue.12, pp.2213-2223, 2013.

A. Pigneux, M. C. Béné, and P. Guardiola, Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study, J Clin Oncol, vol.35, issue.4, pp.387-393, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01529184

H. Döhner, E. H. Estey, and S. Amadori, Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-474, 2010.

D. A. Arber, A. Orazi, and R. Hasserjian, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-2405, 2016.